159
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

External Validation of the Nelson Equation for Kidney Function Decline in Patients with Acute Ischemic Stroke or Transient Ischemic Attack

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 901-909 | Received 17 Feb 2023, Accepted 01 Jun 2023, Published online: 06 Jun 2023

References

  • Zhao Q, Yan T, Chopp M, et al. Brain-kidney interaction: renal dysfunction following ischemic stroke. J Cereb Blood Flow Metab. 2020;40(2):246–262. doi:10.1177/0271678X19890931
  • Wang D, Liu M, Hao Z, et al. Association between reduced kidney function and clinical outcomes after ischaemic stroke with atrial fibrillation. Eur J Neurol. 2014;21(1):160–166. doi:10.1111/ene.12293
  • Wu VC, Wu PC, Wu CH, et al. The impact of acute kidney injury on the long-term risk of stroke. J Am Heart Assoc. 2014;3:e000933. doi:10.1161/JAHA.114.000933
  • Zorrilla-Vaca A, Ziai W, Connolly ES, et al. Acute kidney injury following acute ischemic stroke and intracerebral hemorrhage: a meta-analysis of prevalence rate and mortality risk. Cerebrovasc Dis. 2018;45(1–2):1–9. doi:10.1159/000479338
  • Tsagalis G, Akrivos T, Alevizaki M, et al. Long-term prognosis of acute kidney injury after first acute stroke. Clin J Am Soc Nephrol. 2009;4(3):616–622. doi:10.2215/CJN.04110808
  • Tummalapalli SL, Estrella MM. Predicting risk of kidney disease: is risk-based kidney care on the horizon? JAMA. 2019;322(21):2079–2081. doi:10.1001/jama.2019.17378
  • Nelson RG, Grams ME, Ballew SH, et al. Development of risk prediction equations for incident chronic kidney disease. JAMA. 2019;322(21):2104–2114. doi:10.1001/jama.2019.17379
  • Chien KL, Lin HJ, Lee BC, et al. A prediction model for the risk of incident chronic kidney disease. Am J Med. 2010;123(9):836–846.e832. doi:10.1016/j.amjmed.2010.05.010
  • O’Seaghdha CM, Lyass A, Massaro JM, et al. A risk score for chronic kidney disease in the general population. Am J Med. 2012;125(3):270–277. doi:10.1016/j.amjmed.2011.09.009
  • Wang Y, Jing J, Meng X, et al. The Third China National Stroke Registry (CNSR-III) for patients with acute ischaemic stroke or transient ischaemic attack: design, rationale and baseline patient characteristics. Stroke Vasc Neurol. 2019;4(3):158–164. doi:10.1136/svn-2019-000242
  • Adams HP, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35–41. doi:10.1161/01.STR.24.1.35
  • Draznin B, Aroda VR, Bakris G, et al. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022. Diabetes Care. 2022;45:S17–S38.
  • Carey RM, Wright JT, Taler SJ, et al. Guideline-driven management of hypertension: an evidence-based update. Circ Res. 2021;128(7):827–846. doi:10.1161/CIRCRESAHA.121.318083
  • Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–612. doi:10.7326/0003-4819-150-9-200905050-00006
  • Luo Y, Wang X, Wang Y, et al. Association of glomerular filtration rate with outcomes of acute stroke in type 2 diabetic patients: results from the China National Stroke Registry. Diabetes Care. 2014;37:173–179. doi:10.2337/dc13-1931
  • Inker LA, Astor BC, Fox CH, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63(5):713–735. doi:10.1053/j.ajkd.2014.01.416
  • Hayden D, McCarthy C, Akijian L, et al. Renal dysfunction and chronic kidney disease in ischemic stroke and transient ischemic attack: a population-based study. Int J Stroke. 2017;12(7):761–769. doi:10.1177/1747493017701148
  • Putaala J, Haapaniemi E, Gordin D, et al. Factors associated with impaired kidney function and its impact on long-term outcome in young ischemic stroke. Stroke. 2011;42(9):2459–2464. doi:10.1161/STROKEAHA.110.612721
  • Fandler-Höfler S, Odler B, Kneihsl M, et al. Acute and chronic kidney dysfunction and outcome after stroke thrombectomy. Transl Stroke Res. 2021;12(5):791–798. doi:10.1007/s12975-020-00881-2
  • Kelly DAO, Li L, Burgess AI, et al. Associations of blood biomarkers with glomerular filtration rate in patients with TIA and stroke: population-based study. Stroke Vasc Neurol. 2021;6(1):48–56. doi:10.1136/svn-2020-000422
  • Shimoyama T, Sato T, Sakamoto Y, et al. Urinary biomarkers of kidney tubule injury, risk of acute kidney injury, and mortality in patients with acute ischaemic stroke treated at a stroke care unit. Eur J Neurol. 2020;27(12):2463–2472. doi:10.1111/ene.14448
  • Tao Y, Dong W, Li Z, et al. Proteinuria as an independent risk factor for contrast-induced acute kidney injury and mortality in patients with stroke undergoing cerebral angiography. J Neurointerv Surg. 2017;9:445–448. doi:10.1136/neurintsurg-2016-012349
  • Ikeme JC, Pergola PE, Scherzer R, et al. Cerebral white matter hyperintensities, kidney function decline, and recurrent stroke after intensive blood pressure lowering: results from the secondary prevention of small subcortical strokes (SPS 3) trial. J Am Heart Assoc. 2019;8:e010091. doi:10.1161/JAHA.118.010091
  • Lin SY, Tang SC, Tsai LK, et al. Incidence and risk factors for acute kidney injury following mannitol infusion in patients with acute stroke: a retrospective cohort study. Medicine. 2015;94:e2032. doi:10.1097/MD.0000000000002032
  • Kamouchi M, Sakai H, Kiyohara Y, et al. Acute kidney injury and edaravone in acute ischemic stroke: the Fukuoka Stroke Registry. J Stroke Cerebrovasc Dis. 2013;22(8):e470–e476. doi:10.1016/j.jstrokecerebrovasdis.2013.05.018
  • Qureshi AI, Aslam H, Zafar W, et al. Acute kidney injury in acute ischemic stroke patients in clinical trials. Crit Care Med. 2020;48:1334–1339. doi:10.1097/CCM.0000000000004464
  • Demel SL, Grossman AW, Khoury JC, et al. Association between acute kidney disease and intravenous dye administration in patients with acute stroke: a population-based study. Stroke. 2017;48:835–839. doi:10.1161/STROKEAHA.116.014603
  • Gadalean F, Simu M, Parv F, et al. The impact of acute kidney injury on in-hospital mortality in acute ischemic stroke patients undergoing intravenous thrombolysis. PLoS One. 2017;12:e0185589. doi:10.1371/journal.pone.0185589
  • Stuveling EM, Hillege HL, Bakker SJ, et al. C-reactive protein is associated with renal function abnormalities in a non-diabetic population. Kidney Int. 2003;63(2):654–661. doi:10.1046/j.1523-1755.2003.00762.x
  • Wang HR, Chen DL, Zhao M, et al. C-reactive protein induces interleukin-6 and thrombospondin-1 protein and mRNA expression through activation of nuclear factor-ĸB in HK-2 cells. Kidney Blood Press Res. 2012;35:211–219. doi:10.1159/000332402
  • Lee BT, Ahmed FA, Hamm LL, et al. Association of C-reactive protein, tumor necrosis factor-alpha, and interleukin-6 with chronic kidney disease. BMC Nephrol. 2015;16:77. doi:10.1186/s12882-015-0068-7
  • Rhyu DY, Yang Y, Ha H, et al. Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. J Am Soc Nephrol. 2005;16:667–675. doi:10.1681/ASN.2004050425
  • Tan RJ, Liu Y. Matrix metalloproteinases in kidney homeostasis and diseases. Am J Physiol Renal Physiol. 2012;302:F1351–F1361. doi:10.1152/ajprenal.00037.2012
  • Krowicki ZK, Kapusta DR. Microinjection of glycine into the hypothalamic paraventricular nucleus produces diuresis, natriuresis, and inhibition of central sympathetic outflow. J Pharmacol Exp Ther. 2011;337:247–255. doi:10.1124/jpet.110.175398
  • Mracsko E, Liesz A, Karcher S, et al. Differential effects of sympathetic nervous system and hypothalamic-pituitary-adrenal axis on systemic immune cells after severe experimental stroke. Brain Behav Immun. 2014;41:200–209. doi:10.1016/j.bbi.2014.05.015
  • Zhang W, Wang W, Yu H, et al. Interleukin 6 underlies angiotensin II-induced hypertension and chronic renal damage. Hypertension. 2012;59:136–144. doi:10.1161/HYPERTENSIONAHA.111.173328
  • Puddu P, Puddu GM, Cravero E, et al. The involvement of circulating microparticles in inflammation, coagulation and cardiovascular diseases. Can J Cardiol. 2010;26(4):140–145. doi:10.1016/S0828-282X(10)70371-8
  • Venkat P, Chen J, Chopp M. Exosome-mediated amplification of endogenous brain repair mechanisms and brain and systemic organ interaction in modulating neurological outcome after stroke. J Cereb Blood Flow Metab. 2018;38:2165–2178. doi:10.1177/0271678X18782789
  • Zhang W, Zhou X, Zhang H, et al. Extracellular vesicles in diagnosis and therapy of kidney diseases. Am J Physiol Renal Physiol. 2016;311(5):F844–F851. doi:10.1152/ajprenal.00429.2016
  • van Overbeek EC, Staals J, van Oostenbrugge RJ. Decreased kidney function relates to progression of cerebral microbleeds in lacunar stroke patients. Int J Stroke. 2016;11(6):695–700. doi:10.1177/1747493016641966